News and practice for haematology nurse specialists
The National Institute for Health and Care Excellence has recommended eculizumab (Soliris) for treating a rare life-threatening blood disorder called atypical Haemolytic Uraemic Syndrome (aHUS).
The National Institute for Health and Care Excellence has approved the anti-clotting drug dabigatran (Pradaxa) as an option for treating and preventing deep vein thrombosis and pulmonary embolism.
Latest research: haematology
The number of patients with both type 2 diabetes and dementia is rising, which poses new challenges in blood glucose monitoring and medicines administration.
Nurses are increasingly likely to care for patients with type 2 diabetes. This learning unit will increase understanding of its causes, prevention, treatment and management.
Looking for a new career?
Anaemia is often overlooked as its symptoms – shortness of breath, palpitations, headache and dizziness, for example – can be put down to a range of other conditions.